Preliminary study shows Ebola vaccine 100 percent effective
Stephen FellerWASHINGTON, July 31 (UPI) -- A vaccine for the Ebola virus has shown 100 percent efficacy in the midst of a Phase III clinical trial in Guinea, researchers announced today. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 31, 2015 Category: Consumer Health News Source Type: news

Getting Closer to an Ebola Vaccine
MSF is heavily involved in the trial by administering the vaccine to 1,200 frontline workers in Guinea. Language English (Source: MSF News)
Source: MSF News - July 31, 2015 Category: Global & Universal Authors: Melissa Pracht Source Type: news

Ebola vaccine efficacy trial suggest vaccine provides high protection against disease
Tests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 31, 2015 Category: Science Source Type: news

World "on the verge of an effective Ebola vaccine"
Trial in Guinea tested thousands of people exposed to deadly virus and the results point to "a game-changer" (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 31, 2015 Category: Consumer Health News Source Type: news

Effective Ebola Vaccine May Be Here: Health Officials
Initial trials in Guinea show 100 percent effectiveness, larger trials are planned, WHO says (Source: WebMD Health)
Source: WebMD Health - July 31, 2015 Category: Consumer Health News Source Type: news

Ebola vaccine shows huge promise in the field
The rVSV-ZEBOV vaccine is “highly efficacious” in preventing the disease, shows clinical trial in Guinea. (Source: SciDev.Net)
Source: SciDev.Net - July 31, 2015 Category: Global & Universal Source Type: news

Experimental Ebola Vaccine Could Stop Virus in West Africa
Ebola vaccine seems effective, could stop current outbreak and prevent future disasters (Source: ABC News: Health)
Source: ABC News: Health - July 31, 2015 Category: Consumer Health News Tags: Health Source Type: news

WHO's Chan says initial results from Ebola vaccine trial 'promising'
GENEVA (Reuters) - Initial results from an Ebola vaccine trial in Guinea are "exciting" and "promising" and suggest the shot could help bring an end to West Africa's epidemic, World Health Organization director general Margaret Chan said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - July 31, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

WHO: Trials show new Ebola vaccine is 'highly effective'
(Source: CNN.com - Health)
Source: CNN.com - Health - July 31, 2015 Category: Consumer Health News Source Type: news

Ebola VSV-EBOV vaccine 'could be a game changer in the fight against deadly virus'
The VSV-EBOLV vaccine is being trialled in Guinea, the nation at the heart of the largest Ebola outbreak on record, which has so far killed more than 11,000 people - the majority in West Africa. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2015 Category: Consumer Health News Source Type: news

Getting Closer to an Ebola Vaccine
July 31, 2015 MSF is heavily involved in the trial by administering the vaccine to 1,200 frontline workers in Guinea. (Source: MSF News)
Source: MSF News - July 31, 2015 Category: Global & Universal Authors: Melissa Pracht Source Type: news

West Africa: Ebola Vaccine 'Highly Effective', Results Show
[WHO] Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts - the Data and Safety Monitoring Board -- that conducted the review, advised that the trial should continue. Preliminary results from analysis of these interim data are published today in the British journal The Lancet. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 31, 2015 Category: African Health Source Type: news

‘Remarkable’ Ebola vaccine shows 100% protection
Vaccine has been tested on 4,000 people (Source: The Irish Times - Health)
Source: The Irish Times - Health - July 31, 2015 Category: Consumer Health News Source Type: news

Effective Ebola Vaccine May Be Here: Health Officials
Initial trials in Guinea show 100 percent effectiveness, larger trials are planned, WHO says Source: HealthDay Related MedlinePlus Pages: Ebola, Immunization (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 31, 2015 Category: Consumer Health News Source Type: news

VIDEO: Trials could lead to first Ebola vaccine
Initial results from an Ebola vaccine trial in Guinea are "exciting" and "promising", according to the World Health Organization. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 31, 2015 Category: Consumer Health News Source Type: news

Ebola vaccine success offers hope after trial shows 100 per cent success rate
The world is for the first time on the verge of being able to protect humans against Ebola, the World Health Organization (WHO) said on 31 July, as data from a trial in Guinea showed a vaccine was 100 per cent effective. (Source: The Independent - Science)
Source: The Independent - Science - July 31, 2015 Category: Science Tags: Health News Source Type: news

'Remarkable' Ebola vaccine created with 100% success rate
More than 7,500 people who came into contact with Ebola victims were protected from the deadly disease by a new vaccine (Source: Telegraph Health)
Source: Telegraph Health - July 31, 2015 Category: Consumer Health News Tags: cure ebola guinea deaths symptoms victims sierra leone UK vaccine Source Type: news

Vaccine success holds hope for end to deadly scourge of Ebola
LONDON (Reuters) - The world is for the first time on the verge of being able to protect humans against Ebola, the World Health Organization (WHO) said on Friday, as data from a trial in Guinea showed a vaccine was 100 percent effective. (Source: Reuters: Health)
Source: Reuters: Health - July 31, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

In Interim Results from Phase 3 Study, Merck’s Investigational Ebola Vaccine Efficacious; Study is Continuing
Dateline City: KENILWORTH, N.J. Global Collaboration Enabled Vaccine to Move from First-in-Human Studies to Initial Phase 3 Results Within One Year KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (known as MSD outside the US and Canada) said today that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100 percent efficacy in an analysis of interim data from a Phase 3 ring vaccination trial in Guinea. Preliminary conclusions from this study, which is continuing, were published on-line today in The Lancet. Language: ...
Source: Merck.com - Research and Development News - July 31, 2015 Category: Pharmaceuticals Tags: Ebola Newsroom Research and Development News Corporate News Latest News Source Type: news

Ebola vaccine results 'remarkable'
A vaccine against the deadly Ebola virus has led to 100% protection in a pioneering trial described as a "potential game-changer". (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 31, 2015 Category: Consumer Health News Source Type: news

Experimental Ebola Vaccine Tested in Guinea Shows Promise, Report Says
The report, published in the British medical journal The Lancet, indicated that the vaccine “might be safe and highly efficacious in preventing Ebola virus disease.” (Source: NYT)
Source: NYT - July 31, 2015 Category: American Health Authors: SHERI FINK Tags: Epidemics Liberia Clinical Trials Academic and Scientific Journals Preventive Medicine Doctors Without Borders Ebola Virus Lancet, The (Journal) Medicine and Health Sierra Leone Vaccination and Immunization Africa World Health Orga Source Type: news

Experimental Ebola Vaccine Tested in Guinea Shows Promise, Report Says
The report, published in the British medical journal The Lancet, indicated that the vaccine “might be safe and highly efficacious in preventing Ebola virus disease.” (Source: NYT Health)
Source: NYT Health - July 31, 2015 Category: Consumer Health News Authors: SHERI FINK Tags: Epidemics Liberia Clinical Trials Academic and Scientific Journals Preventive Medicine Doctors Without Borders Ebola Virus Lancet, The (Journal) Medicine and Health Sierra Leone Vaccination and Immunization Africa World Health Orga Source Type: news

Top stories: An Ebola vaccine, extrasolar northern lights, and Rosetta’s comet results
This week’s top science news (Source: ScienceNOW)
Source: ScienceNOW - July 31, 2015 Category: Science Source Type: news

U.S. government begins human trials of genetically modified Ebola vaccine
(NaturalNews) Just as predicted, vaccine companies are soon planning to unveil an Ebola vaccine in response to the manufactured Ebola outbreak that's allegedly still spreading throughout West Africa. A genetically-modified (GM) Ebola vaccine that's currently undergoing human clinical... (Source: NaturalNews.com)
Source: NaturalNews.com - July 31, 2015 Category: Consumer Health News Source Type: news

World on the verge of an effective Ebola vaccine
Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola. The independent body of international experts - the Data and Safety Monitoring Board – that conducted the review, advised that the trial should continue. Preliminary results from analyses of these interim data are published today in the British journal The Lancet. "This is an extremely promising development," said Dr Margaret Chan, Director-General of the World Health Organization. "The credit goes to the Guinean Government, the people living i...
Source: WHO news - July 31, 2015 Category: Global & Universal Tags: ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola Source Type: news

HHS Partnership Advances Experimental Ebola Drug
One of the nation's centers dedicated to developing and manufacturing drugs and vaccines for emergencies will produce a novel therapeutic drug to treat Ebola virus disease under a task order issued by the U.S. Department of Health and Human Services (HHS). (Source: PHPartners.org)
Source: PHPartners.org - July 24, 2015 Category: Global & Universal Source Type: news

Liberia: LCP, Prevail Launch Awareness On Ebola Vaccine Study
[New Dawn] The Liberia Crusader for Peace or LCP in collaboration with the Partnership for Research on Ebola Virus in Liberia orPREVAIL has conducted a day's long awareness and sensitization for community members on the recent Ebola study launched by the Liberia-US joint clinical research partnership at the John F. Kennedy Hospital in Sinkor, Monrovia. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 24, 2015 Category: African Health Source Type: news

Mayo Clinic Minute 7/23/2015
In today's Mayo Clinic Minute with Vivien Williams: New hope in the fight against the Ebola virus, an extreme heat safety reminder and the link between mobile phone use and depression. For more information, click here for the Ebola vaccine study and here for the mobile phone study. Journalists: Video is available in the downloads. [TRT :56] Click here for the script. https://youtu.be/YuDSVNfBiHw (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 23, 2015 Category: Databases & Libraries Source Type: news

Novavax reports results of Phase I Ebola GP Vaccine trial
Clinical-stage vaccine firm Novavax has presented positive top-line data from a Phase I clinical trial of its Ebola virus glycoprotein (GP)recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M (TM). (Source: Drug Development Technology)
Source: Drug Development Technology - July 22, 2015 Category: Pharmaceuticals Source Type: news

Ghana: Fear Not, Ebola Vaccine Trial Is Safe - Prof. Binka
[Ghanaian Chronicle] Hohoe -The Vice Chancellor of the University of Health and Allied Sciences (UHAS), Prof. Fred Binka has allayed fears among Ghanaians, especially the people of Hohoe, about the pending Ebola vaccine trial that would take place at the Research center in the town. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 21, 2015 Category: African Health Source Type: news

Novavax's Ebola vaccine shows promise in early-stage trial
(Reuters) - Novavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults. (Source: Reuters: Health)
Source: Reuters: Health - July 21, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

The results are in: Inhalable Ebola vaccine, spread of Lyme disease
(Source: CNN.com - Health)
Source: CNN.com - Health - July 17, 2015 Category: Consumer Health News Source Type: news

Oxford Ebola vaccine study moves to next phase
(University of Oxford) Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The Phase II study aims to recruit more than 600 healthy adult volunteers in the UK and France. The vaccine regimen used in the study involves two different components, Ad26.ZEBOV and MVA-BN FILO, given a few weeks apart. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 15, 2015 Category: Infectious Diseases Source Type: news

This Needle-Free Ebola Vaccine Could Change Everything
Scientists have announced the creation of an aerosolized vaccine capable of fully protecting rhesus macaques, a species of monkey commonly used in Ebola research, against the most deadly strain of Ebola virus.     If the finding is confirmed in human trials, the vaccine could be a major boon to rural areas because you don’t have to be a healthcare professional to administer the dose, said lead author Michelle Meyer, a postdoctoral fellow at the University of Texas Medical Branch at Galveston.    “A needle-free, inhalable vaccine against Ebola presents certain advantages,” said Meyer in...
Source: Science - The Huffington Post - July 14, 2015 Category: Science Source Type: news

Inhalable Ebola vaccine effective in primates
Stephen FellerGALVESTON, Texas, July 14 (UPI) -- One dose of an inhalable Ebola vaccine was enough to protect monkeys from being infected by 1,000 times the fatal dose of the disease, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 14, 2015 Category: Consumer Health News Source Type: news

Ebola vaccine trial begins in Senegal
(University of Oxford) A trial evaluating an Ebola vaccine has begun in Dakar, after initial work at Oxford's Jenner Institute. The announcement comes as a conference in Oxford discusses the global response to Ebola and implications for future drug and vaccine development.The first volunteers at Centre Hospitalier Universitaire le Dantec, Dakar, received an initial vaccination with a booster one week later. This short timescale could provide an option for a rapid vaccination programme in an outbreak. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 14, 2015 Category: Infectious Diseases Source Type: news

Aerosolized vaccine protects primates against Ebola
Scientists have developed an inhalable vaccine that protects primates against Ebola. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 13, 2015 Category: Science Source Type: news

Inhaled Ebola Vaccine Stops Virus in Monkeys, Study Finds
A study released on Monday offered hope for immunizing a wide array of people, including those who live in places with limited professional medical care. (Source: NYT Health)
Source: NYT Health - July 13, 2015 Category: Consumer Health News Authors: NICHOLAS ST. FLEUR Tags: National Institutes of Health Research Ebola Virus Vaccination and Immunization Source Type: news

Researchers develop aerosolized vaccine that protects primates against Ebola
(University of Texas Medical Branch at Galveston) A collaborative team from the University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 13, 2015 Category: Infectious Diseases Source Type: news

Ghana: Who Must Answer Gaas
[Fahamu] Global pharmaceutical giant GlaxoSmithKline and the US National Institutes of Health announced in January the start of clinical trials of an Ebola vaccine in Ghana. Local scientists and the public have raised questions about this project. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 6, 2015 Category: African Health Source Type: news

Ghana: WHO Must Answer to GAAS - the World Health Organisation Must Respond to the Queries of the Ghana Academy of Arts and Sciences)
[Ghanaian Chronicle] The World Health Organisation (WHO) and its agents in Ghana should not seek to pull the wool over the eyes of Ghanaians over public outcry against the Ebola Vaccine trial which has forced the trial lead scientist, Prof. Fred Binka, to offer to "personally undergo the clinical trial as proof of its safety", in an interview with Starr News. Following Prof. Binka's heels is the Ministry of Health embarking on "an education program to ally public fears." (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 3, 2015 Category: African Health Source Type: news

West Africa: A Conversation With - Ripley Ballou, Head of Gsk's Ebola Vaccine Research
[Ebola Deeply] Dr. Ripley Ballou, who heads GlaxoSmithKline (GSK)'s Ebola vaccine research, is also the co-creator of the RTS,S malaria vaccine. Following 30 years researching the malaria vaccine, Ballou led the team that fast-tracked the Ebola vaccine within just a few months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 2, 2015 Category: African Health Source Type: news

Three Ebola virus variants identified in Guinea
(Institut Pasteur) Sequencing the genome of Ebola virus strains circulating in Guinea has allowed scientists at the Institut Pasteur in Dakar and in Paris, the CNRS and the University of Sydney to retrace the spread of the virus and monitor its evolution in the country where the outbreak started. Characterization of the genetic variations of the virus is crucial to ensure the continued efficacy of diagnostic tools and for the development of effective treatments and vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 24, 2015 Category: Infectious Diseases Source Type: news

NIH Expands Ebola Vaccine Research Beyond Liberia
The National Institutes of Health has widened its research into Sierra Leone and Guinea, a move that increases the chances of getting definitive results from clinical studies. (Source: WSJ.com: Health)
Source: WSJ.com: Health - June 24, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news

Liberia: Ebola Vaccine Volunteers Show No Side-Effects
[NEWS] Researchers of a joint U.S., Liberia partnership have indicated that more than 1,500 participants of a recent clinical trial of two vaccines to prevent the Ebola virus showed no sign of negative side-effects. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 23, 2015 Category: African Health Source Type: news

Ghana: Allowing Ebola Vaccine Trial Shows NDC Insensitivity - Chairman Wontumi
[Ghanaian Chronicle] Kumasi -THE ASHANTI Regional Chairman of the opposition New Patriotic Party (NPP), Mr. Bernard Antwi Boasiako has commended Members of Parliament for pulling a break on the intended trial of the Ebola Vaccine in the Volta Region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 23, 2015 Category: African Health Source Type: news

Liberia: Ebola Vaccine Volunteers Showing No Serious Side Effects - Official
[LINA] The 1,500 participants of the recent clinical trials of two vaccines to prevent the Ebola virus have since their inoculation reported no serious side effects, an official has disclosed. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 23, 2015 Category: African Health Source Type: news

Ghana: Food and Drug Authority Educates Public On Ebola Vaccine Trial
[Ghana Govt.] A public forum, which aimed to sensitize the citizenry on the Ebola Vaccine trial and scheduled to take place in Hohoe in the Volta Region, has taken place in Accra. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 23, 2015 Category: African Health Source Type: news

Early detection of highly pathogenic influenza viruses
(Justus Liebig University) Lack of appropriate drugs and vaccines during the influenza A virus pandemic in 2009, the recent Ebola epidemic in West Africa, as well as the ongoing Middle Eastern Respiratory Syndrome-Coronavirus outbreak demonstrates that the world is only insufficiently prepared for global attacks of emerging infectious diseases and that the handling of such threats remains a great challenge. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 23, 2015 Category: Infectious Diseases Source Type: news